vcvibes

Avant Bio LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

Website
https://www.avant.bio/
HQ
NY
Open their pitch form

Avant Bio LLC backs innovative Life Sciences and Healthtech companies developing Therapeutic-Enabling Technologies that aim to make therapies more accessible. Daniella Kranjac is Founding General Partner, and Sebastien Latapie and Ole Henrik Bang-Andreasen are Partners. Portfolio companies include Abbelight, Intrepid Labs, Nomic Bio, PathPresenter, and PL BioScience.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsHealthtechNot enough dated deals
RegionsNot statedNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Avant Bio Fund II LP

Avant Bio invests in innovative life sciences and healthtech companies developing Therapeutic Enabling Technologies, including biomanufacturing tools and automation, machine learning and AI applications, healthtech, techbio, and contract services, to make therapies more accessible. Inferred from the firm's website

2023$57.45M (Form D)Open, writing first checks

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://www.avant.bio/
  2. https://avantbio.typeform.com/submission?typeform-source=//avant.bio/contact/
  3. https://avant.bio/avant-bio-names-maik-w-jornitz-and-lukas-utiger-as-operating-advisors-to-strengthen-portfolio-operational-support-and-strategic-growth/
  4. https://avant.bio/news-resources/
  5. https://avant.bio/nomic-partners-with-novo-nordisk-to-scale-proteomics-for-drug-discovery/
  6. https://avant.bio/our-approach/
  7. https://avant.bio/pathpresenter-partners-with-leading-global-cancer-center-to-integrate-ai-module-for-oncology-research/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026